Get the Stockscreener App
0.6923
41.82%
-0.4977
After Hours:
.74
0.0477
+6.89%
Bioatla Inc Stock (BCAB) Forecast
The Bioatla Inc (BCAB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.42, representing a +1,983% increase from the current price of $0.6923. The highest analyst price target is $17.40, and the lowest is $11.44.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BCAB Price Target
Average 8.9873
(+1,198% Upside)
Is Bioatla Inc (BCAB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 19.59 | Buy |
| STOCH(9,6) | 5.0289 | Buy |
| STOCHRSI(14) | 4.2771 | Buy |
| MACD(12,26) | -0.1872 | Sell |
| ADX(14) | 20.91 | Neutral |
| William %R | -97.88 | Buy |
| CCI(14) | -268.33 | Sell |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.3362
Sell
|
1.2556
Sell
|
| MA20 |
1.4776
Sell
|
1.4221
Sell
|
| MA50 |
1.7458
Sell
|
1.6273
Sell
|
| MA100 |
1.7568
Sell
|
1.7453
Sell
|
| MA200 |
2.0038
Sell
|
1.8465
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, BCAB could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on BCAB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 19.59 indicates that BCAB is oversold. This indicates that BCAB price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 5.0289 indicates that BCAB is oversold. This indicates that BCAB price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.2771 indicates that BCAB is oversold. This suggests that BCAB price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 20.91 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -268.33 indicates that BCAB is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term BCAB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Bioatla Inc financial reports and earnings history, Bioatla Inc (BCAB) stock could reach $31.93 by 2030, $93.39 by 2040 and $78.05 by 2050. See the projected annual prices until 2050 of the Bioatla Inc stock below:
- Bioatla Inc (BCAB) is expected to reach an average price of $23.78 in 2035, with a high prediction of $25.13 and a low estimate of $23.79. This indicates an $3,335% rise from the last recorded price of $0.6923.
- Bioatla Inc (BCAB) stock is projected to chart a bullish course in 2040, with an average price target of $93.41, representing an $13,393% surge from its current level. The forecast ranges from a conservative $94.50 to a sky-high $93.39.
- Our analysts predict Bioatla Inc (BCAB) to jump 16,849% by 2045, soaring from $117.63 to an average price of $117.34, potentially reaching $117.99. While $117.63 is the low estimate, the potential upside is significant.
- Bioatla Inc (BCAB) stock is expected to climb by 2050, reaching an average of $75.86, a $10,858% jump from its current level. However, a wide range of estimates exists, with high and low targets of $78.05 and $76.11, respectively, highlighting the market's uncertainty.
Bioatla Inc Stock (BCAB) Year by Year Forecast
Bioatla Inc Stock (BCAB) Price Forecast for 2025
Bioatla Inc Stock (BCAB) is expected to reach an average price of $8.9873 in 2025, with a high prediction of $17.47 and a low estimate of $0.505. This indicates an +1,198% rise from the last recorded price of $0.6923.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $14.82 | $11.44 | $17.40 | +2,040% |
| February, 2025 | $9.0732 | $9.0332 | $16.52 | +1,211% |
| March, 2025 | $1.9111 | $0.9136 | $8.9552 | +176.06% |
| April, 2025 | $3.701 | $0.8531 | $6.9141 | +434.60% |
| May, 2025 | $1.131 | $0.505 | $5.313 | +63.37% |
| June, 2025 | $3.4331 | $2.739 | $2.5131 | +395.90% |
| July, 2025 | $12.79 | $7.491 | $12.77 | +1,748% |
| August, 2025 | $15.15 | $14.53 | $14.86 | +2,088% |
| September, 2025 | $15.45 | $15.30 | $15.27 | +2,131% |
| October, 2025 | $16.51 | $16.00 | $15.73 | +2,284% |
| November, 2025 | $17.64 | $16.69 | $17.47 | +2,448% |
| December, 2025 | $16.28 | $16.61 | $17.36 | +2,252% |
Bioatla Inc Stock (BCAB) Price Forecast for 2026
The predicted value for Bioatla Inc (BCAB) in 2026 is set at an average of $10.61. Estimates vary from a peak of $16.21 to a trough of $5.0222, indicating an +1,433% surge from the present price of $0.6923.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $15.72 | $15.87 | $16.21 | +2,171% |
| February, 2026 | $14.69 | $14.46 | $14.43 | +2,022% |
| March, 2026 | $8.4458 | $9.3658 | $13.98 | +1,120% |
| April, 2026 | $8.8059 | $8.9759 | $8.5319 | +1,172% |
| May, 2026 | $9.448 | $9.097 | $9.033 | +1,265% |
| June, 2026 | $6.7001 | $8.3901 | $9.131 | +867.80% |
| July, 2026 | $5.4602 | $5.0222 | $5.3581 | +688.70% |
| August, 2026 | $6.1722 | $6.1682 | $5.8362 | +791.56% |
| September, 2026 | $9.4223 | $9.9473 | $10.60 | +1,261% |
| October, 2026 | $10.14 | $9.9904 | $10.00 | +1,365% |
| November, 2026 | $10.20 | $10.22 | $10.04 | +1,373% |
| December, 2026 | $8.4766 | $8.5766 | $9.5945 | +1,124% |
Bioatla Inc Stock (BCAB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Bioatla Inc (BCAB) is $4.8216, with a high forecast of $7.8246 and a low forecast of $1.8186. This indicates an +596.46% increase from the last price of $0.6923.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $8.1887 | $8.2006 | $7.8246 | +1,083% |
| February, 2027 | $6.9307 | $7.2607 | $7.8066 | +901.12% |
| March, 2027 | $7.0708 | $7.1388 | $7.2298 | +921.35% |
| April, 2027 | $6.7629 | $6.8369 | $6.8588 | +876.87% |
| May, 2027 | $6.245 | $6.375 | $6.5509 | +802.06% |
| June, 2027 | $6.3951 | $6.343 | $6.3921 | +823.74% |
| July, 2027 | $6.1171 | $6.2811 | $6.1541 | +783.60% |
| August, 2027 | $5.4292 | $5.4792 | $5.4952 | +684.23% |
| September, 2027 | $4.0793 | $4.4493 | $4.9672 | +489.24% |
| October, 2027 | $3.7614 | $3.6284 | $3.3404 | +443.32% |
| November, 2027 | $2.4235 | $2.9835 | $3.4094 | +250.06% |
| December, 2027 | $1.6936 | $1.8186 | $2.3795 | +144.63% |
Bioatla Inc Stock (BCAB) Price Forecast for 2028
In 2028, Bioatla Inc (BCAB) is projected to reach an average price of $14.38, with a high projection of $28.21 and a low estimate of $0.5461. This indicates an +1,977% rise from the last price of $0.6923.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0956 | $0.7256 | $1.5796 | -86.19% |
| February, 2028 | $1.0727 | $0.6437 | $0.9197 | +54.95% |
| March, 2028 | $23.78 | $0.9257 | $28.21 | +3,335% |
| April, 2028 | $13.04 | $17.84 | $13.34 | +1,784% |
| May, 2028 | $6.9376 | $9.4943 | $9.0176 | +902.10% |
| June, 2028 | $7.2466 | $0.5461 | $17.44 | +946.74% |
| July, 2028 | $7.6107 | $8.7007 | $6.7337 | +999.34% |
| August, 2028 | $14.08 | $13.05 | $11.95 | +1,934% |
| September, 2028 | $12.27 | $12.53 | $12.08 | +1,672% |
| October, 2028 | $12.24 | $12.72 | $11.69 | +1,668% |
| November, 2028 | $11.23 | $13.99 | $11.09 | +1,522% |
| December, 2028 | $16.40 | $10.92 | $11.71 | +2,269% |
Bioatla Inc Stock (BCAB) Price Forecast for 2029
The 2029 price forecast for Bioatla Inc Stock (BCAB) is $29.00 on average, with a high prediction of $37.41 and a low estimate of $20.58. This represents an +4,088% increase from the previous price of $0.6923.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $21.11 | $21.57 | $20.13 | +2,950% |
| February, 2029 | $20.50 | $20.58 | $19.76 | +2,861% |
| March, 2029 | $24.76 | $21.72 | $22.12 | +3,477% |
| April, 2029 | $26.50 | $26.23 | $25.58 | +3,727% |
| May, 2029 | $35.15 | $30.41 | $35.13 | +4,977% |
| June, 2029 | $36.93 | $36.74 | $36.65 | +5,234% |
| July, 2029 | $36.66 | $36.95 | $36.63 | +5,196% |
| August, 2029 | $37.01 | $36.65 | $36.47 | +5,247% |
| September, 2029 | $37.58 | $37.05 | $37.41 | +5,328% |
| October, 2029 | $35.51 | $35.84 | $37.16 | +5,029% |
| November, 2029 | $34.38 | $34.53 | $35.30 | +4,867% |
| December, 2029 | $32.79 | $32.69 | $32.95 | +4,636% |
Bioatla Inc Stock (BCAB) Price Forecast for 2030
Bioatla Inc Stock (BCAB) is expected to reach an average price of $24.95 in 2030, with a high forecast of $31.93 and a low forecast of $17.97. This signifies an +3,504% surge from the last price of $0.6923.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $26.06 | $26.61 | $31.93 | +3,664% |
| February, 2030 | $25.62 | $25.79 | $25.77 | +3,601% |
| March, 2030 | $25.70 | $25.63 | $25.28 | +3,612% |
| April, 2030 | $22.38 | $24.07 | $25.24 | +3,133% |
| May, 2030 | $20.43 | $20.13 | $20.90 | +2,851% |
| June, 2030 | $20.57 | $21.00 | $20.52 | +2,872% |
| July, 2030 | $23.11 | $23.64 | $24.72 | +3,239% |
| August, 2030 | $23.27 | $23.38 | $23.13 | +3,261% |
| September, 2030 | $22.75 | $22.88 | $22.89 | +3,187% |
| October, 2030 | $20.32 | $20.42 | $22.01 | +2,836% |
| November, 2030 | $19.47 | $19.62 | $19.53 | +2,712% |
| December, 2030 | $17.64 | $17.97 | $18.94 | +2,448% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):